Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

China flag China · Delayed Price · Currency is CNY
7.43
+0.09 (1.23%)
Mar 10, 2026, 3:00 PM CST
41.25%
Market Cap 4.11B
Revenue (ttm) 1.79B
Net Income (ttm) 46.95M
Shares Out 552.92M
EPS (ttm) 0.08
PE Ratio 87.60
Forward PE n/a
Dividend 0.03 (0.38%)
Ex-Dividend Date Jan 9, 2026
Volume 20,660,200
Average Volume 21,313,675
Open 7.38
Previous Close 7.34
Day's Range 7.31 - 7.48
52-Week Range 4.51 - 9.44
Beta 0.86
RSI 63.35
Earnings Date Apr 15, 2026

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chewable tablets, Huperzine A tablets, compound Yimu oral liquid. The company serves hospitals, primary medical institutions, and retail terminals. Henan T... [Read more]

Sector Healthcare
Founded 1993
Employees 2,214
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600222
Full Company Profile

Financial Performance

In 2024, SHA:600222's revenue was 1.94 billion, a decrease of -6.21% compared to the previous year's 2.07 billion. Earnings were 50.53 million, an increase of 16.00%.

Financial Statements

News

There is no news available yet.